← back to search

Jakob P. Cramer

Takeda (Switzerland) · CH
Area of research
Public Health, Environmental and Occupational Health · Infectious Diseases
Research interest
Research interests include Malaria Research and Control, Travel-related health issues, Mosquito-borne diseases and control, and Viral gastroenteritis research and epidemiology.
h-index
41
citations
6,862
works
137
NIH funding
primary concept
Medicine
email

Recent publications

Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults.
2025cited by 3position: contributordoi
Realising the potential of correlates of protection for vaccine development, licensure and use: short summary
npj Vaccines 2024cited by 29position: middledoi
Persistence of the Immune Response to an Intramuscular Bivalent (GI.1/GII.4) Norovirus Vaccine in Adults
2024cited by 0position: contributordoi
Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data
Vaccine 2021cited by 116position: middledoi
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohort
Journal of Infection 2021cited by 31position: middledoi
Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12–13 February 2020
Vaccine 2021cited by 11position: middledoi
A Prospective Study on the Impact and Out-of-Pocket Costs of Dengue Illness in International Travelers
American Journal of Tropical Medicine and Hygiene 2019cited by 16position: middledoi
Business travel-associated illness: a GeoSentinel analysis†
Journal of Travel Medicine 2018cited by 60position: middledoi
Illness in Travelers Returned From Brazil: The GeoSentinel Experience and Implications for the 2014 FIFA World Cup and the 2016 Summer Olympics
Clinical Infectious Diseases 2014cited by 73position: middledoi
Acute Muscular Sarcocystosis: An International Investigation Among Ill Travelers Returning From Tioman Island, Malaysia, 2011-2012
Clinical Infectious Diseases 2014cited by 63position: middledoi
Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala
The Lancet Infectious Diseases 2013cited by 100position: middledoi
Duration of Fecal Shedding of Shiga Toxin–Producing Escherichia coli O104:H4 in Patients Infected During the 2011 Outbreak in Germany: A Multicenter Study
Clinical Infectious Diseases 2013cited by 48position: middledoi
Efficacy of a Travelers' Diarrhea Vaccine System in Travelers to India: Table 1
Journal of Travel Medicine 2013cited by 25position: middledoi
Infectious diseases among travellers and migrants in Europe, EuroTravNet 2010
Eurosurveillance 2012cited by 81position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2024–2025)Ian Escudero · 2 papers (2024–2025) · 2 papers (2024–2025)Robert L. Atmar · Baylor College of Medicine2 papers (2024–2025)R.H. Behrens · London School of Hygiene & Tropical Medicine2 papers (2013–2013)Herbert L. DuPont · The University of Texas MD Anderson Cancer Center2 papers (2013–2013) · 2 papers (2013–2013)Beate Kampmann · Harvard University2 papers (2021–2024)Zhi‐Dong Jiang · Université Paris Cité2 papers (2013–2013)Tomáš Jelı́nek · Sylvester Comprehensive Cancer Center2 papers (2013–2013)Martin P. Grobusch · University of Cape Town2 papers (2012–2019)Frank von Sonnenburg · Boston Medical Center2 papers (2012–2013) · 1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2013–2013)Fernando P. Polack · Vanderbilt University1 papers (2021–2021) · 1 papers (2021–2021) · 1 papers (2012–2012)Tim D. Spector · US Forest Service1 papers (2021–2021) · 1 papers (2019–2019)